TREES (CANN) Stock Price, News & Analysis
Company Description
TREES (OTC Link: CANN) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector and carries a market capitalization of $4.7M.
CANN has declined 55.4% over the past year. Shares last traded at $0.0156.
For FY2023, TREES reported revenue of $18.1M with net income of -$7.1M and diluted earnings per share of -$0.06. The company operates at a net profit margin of -39.1%.
This page collects what Stock Titan holds for CANN, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
TREES (CANN) stock last closed at $0.0156. Over the past 12 months, the stock has lost 55.4%. At a market capitalization of $4.7M, CANN is classified as a micro-cap stock with approximately 115.1M shares outstanding.
CANN Rankings
Latest News
TREES has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition. View all CANN news →
SEC Filings
Financial Highlights
TREES generated $18.1M in revenue in FY2023, retaining a 36.2% gross margin, operating income reached -$4.0M (-21.9% operating margin), and net income was -$7.1M, reflecting a -39.1% net profit margin. Diluted earnings per share stood at -$0.06. The company generated -$1.1M in operating cash flow. With a current ratio of 0.32, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in TREES (CANN) currently stands at 2.2 thousand shares, down 83.5% from the previous reporting period, representing 0.0% of the shares outstanding.
Days to Cover History
Days to cover for TREES (CANN) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
CANN Company Profile & Sector Positioning
TREES (CANN) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CANN often look at related companies in the same sector, including Delivra Health (DHBUF), 1933 Inds (TGIFF), Blueberries Medi (BBRRF), Raphael Pharm (RAPH), and Lftd Partners Inc (LIFD). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CANN's relative position within its industry.